404 filings
Page 12 of 21
6-K
KMDA
Kamada Ltd
2 Aug 17
Current report (foreign)
12:00am
424B5
KMDA
Kamada Ltd
1 Aug 17
Prospectus supplement for primary offering
12:00am
6-K
KMDA
Kamada Ltd
1 Aug 17
Kamada Reports Financial Results for Second Quarter and First Six Months of 2017
12:00am
6-K
KMDA
Kamada Ltd
28 Jul 17
Kamada Announces Pricing of Public Offering of
12:00am
424B5
KMDA
Kamada Ltd
27 Jul 17
Prospectus supplement for primary offering
12:00am
6-K
KMDA
Kamada Ltd
27 Jul 17
Kamada Pre-Announces Certain Preliminary Financial Results for Second Quarter and First
12:00am
6-K
KMDA
Kamada Ltd
20 Jul 17
Current report (foreign)
12:00am
EFFECT
KMDA
Kamada Ltd
13 Jul 17
Notice of effectiveness
12:00am
F-3/A
KMDA
Kamada Ltd
13 Jul 17
Shelf registration (foreign) (amended)
12:00am
CORRESP
KMDA
Kamada Ltd
13 Jul 17
Correspondence with SEC
12:00am
CORRESP
KMDA
Kamada Ltd
12 Jul 17
Correspondence with SEC
12:00am
6-K
KMDA
Kamada Ltd
22 Jun 17
Kamada Announces Withdrawal of European Marketing Authorization Application for Inhaled Alpha-1-Antitrypsin
12:00am
6-K
KMDA
Kamada Ltd
12 Jun 17
Current report (foreign)
12:00am
6-K
KMDA
Kamada Ltd
7 Jun 17
Kamada Provides Update on Clinical Program for Alpha-1 Antitrypsin IV for Treatment of Graft-Versus-Host Disease
12:00am
6-K
KMDA
Kamada Ltd
5 Jun 17
Kamada Announces Appointment of Michal Stein, M.D., as Vice President and Medical Director
12:00am
6-K
KMDA
Kamada Ltd
24 May 17
Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin
12:00am
6-K
KMDA
Kamada Ltd
16 May 17
Kamada Reports 2017 First Quarter Financial Results
12:00am
CT ORDER
KMDA
Kamada Ltd
14 Apr 17
Confidential treatment order
12:00am
20-F
2016 FY
KMDA
Kamada Ltd
Annual report (foreign)
1 Mar 17
12:00am
6-K
KMDA
Kamada Ltd
21 Feb 17
Current report (foreign)
12:00am